Results of Experimental Ligation of the Main Vein with the Use of Cell Technologies


Citar

Texto integral

Acesso aberto Acesso aberto
Acesso é fechado Acesso está concedido
Acesso é fechado Somente assinantes

Resumo

Autologous multipotent mesenchymal stromal cells (MMSC) of bone marrow origin with transfected GFP gene and additionally stained cell membranes were injected to rats through the skin in the projection of ligated femoral vein. The results were evaluated by fluorescent microscopy. No signs of MMSC incorporation into the wall of ligated vessel or reorganized collaterals were detected. Angiogenesis processes involving MMSC were detected in experimental rats within just 4 days and progressed until week 2 postinjection, mainly in granulations at the site of surgical intervention and the cicatrix forming there. Injected MMSC completely formed all tunics of the new vessels and incorporated in the vessels forming from the recipient cells. MMSC and the objects created from them were gradually eliminated with participation of macrophages and replaced by structures formed from the recipient cells.

Sobre autores

I. Maiborodin

Center of New Medical Technologies, Institute of Chemical Biology and Basic Medicine, Siberian Division of the Russian Academy of Sciences

Autor responsável pela correspondência
Email: imai@mail.ru
Rússia, Novosibirsk

V. Morozov

Center of New Medical Technologies, Institute of Chemical Biology and Basic Medicine, Siberian Division of the Russian Academy of Sciences

Email: imai@mail.ru
Rússia, Novosibirsk

V. Matveeva

Center of New Medical Technologies, Institute of Chemical Biology and Basic Medicine, Siberian Division of the Russian Academy of Sciences

Email: imai@mail.ru
Rússia, Novosibirsk

A. Anikeev

Center of New Medical Technologies, Institute of Chemical Biology and Basic Medicine, Siberian Division of the Russian Academy of Sciences

Email: imai@mail.ru
Rússia, Novosibirsk

N. Figurenko

Center of New Medical Technologies, Institute of Chemical Biology and Basic Medicine, Siberian Division of the Russian Academy of Sciences

Email: imai@mail.ru
Rússia, Novosibirsk

R. Maslov

Center of New Medical Technologies, Institute of Chemical Biology and Basic Medicine, Siberian Division of the Russian Academy of Sciences

Email: imai@mail.ru
Rússia, Novosibirsk

G. Chastikin

Center of New Medical Technologies, Institute of Chemical Biology and Basic Medicine, Siberian Division of the Russian Academy of Sciences

Email: imai@mail.ru
Rússia, Novosibirsk

V. Maiborodina

Laboratory of Ultrastructural Bases of Pathology, Institute of Molecular Pathology and Pathomorphology

Email: imai@mail.ru
Rússia, Novosibirsk


Declaração de direitos autorais © Springer Science+Business Media, LLC, part of Springer Nature, 2017

Este site utiliza cookies

Ao continuar usando nosso site, você concorda com o procedimento de cookies que mantêm o site funcionando normalmente.

Informação sobre cookies